103 filings
Page 2 of 6
8-K
l48d0kjt7
11 Sep 08
Departure of Directors or Principal Officers
12:00am
8-K
sxx181f5wy4f9x4wm
2 Sep 08
Triggering Events That Accelerate or Increase a Direct Financial Obligation under an Off-Balance Sheet Arrangement
12:00am
8-K
6m35zopu6mqi6
5 Aug 08
AtheroGenics Reports Second Quarter 2008 Financial Results
12:00am
8-K
fykyz
31 Jul 08
AtheroGenics Reports Positive Results from ANDES Phase 3 Clinical Trial of AGI-1067 in Type 2 Diabetes
12:00am
8-K
e2z vyiculbnc8eei
30 Jun 08
AtheroGenics Receives Notice of Non-Compliance with Listing Requirement for the NASDAQ Global Market
12:00am
8-K
4tcf9pm45m ab5ydwx
24 Apr 08
AtheroGenics Reports First Quarter 2008 Financial Results
12:00am
8-K
ezl10
14 Apr 08
AtheroGenics Announces Encouraging Interim Results from
12:00am
8-K
ob439r88i
7 Apr 08
Entry into a Material Definitive Agreement
12:00am
8-K
m9exoyn
4 Mar 08
Other Events
12:00am
8-K
tmwtgcf scy27vlgp6gi
14 Feb 08
AtheroGenics Reports Fourth Quarter and Year-End 2007 Financial Results
12:00am
8-K
h7737z m7s5hjg
9 Jan 08
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
12:00am
8-K
8baadx c8d72rqzmghe
2 Jan 08
AtheroGenics Receives Notice of Non-Compliance with Listing Requirement for NASDAQ Global Market
12:00am
8-K
h3o2bghj9yghsnqh8e
18 Dec 07
AtheroGenics Completes Enrollment in ANDES Phase III Clinical Trial of AGI-1067
12:00am
8-K
o9ps6rh8r4so
3 Dec 07
Other Events
12:00am
8-K
cz168
3 Dec 07
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12:00am
8-K
7kidug
19 Nov 07
Departure of Directors or Principal Officers
12:00am
8-K
v6agb2
15 Nov 07
Other Events
12:00am
8-K
wrf7s4wr0q0n95qr687b
9 Nov 07
Other Events
12:00am
8-K
2ul6aj f1
25 Oct 07
AtheroGenics Reports Third Quarter 2007 Financial Results
12:00am
8-K
we95t75a
23 Oct 07
Departure of Directors or Principal Officers
12:00am